(Q35888457)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465089%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Impact of antigenemia on the bioactivity of infused anti-Tac antibody: implications for dose selection in antibody immunotherapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465089%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

Jorge A. Carrasquillo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465089%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

R P Junghans

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465089%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

T A Waldmann

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465089%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465089%20AND%20SRC:MED&resulttype=core&format=json

Proceedings of the National Academy of Sciences of the United States of America

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465089%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465089%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465089%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

1752-1757

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465089%20AND%20SRC:MED&resulttype=core&format=json

THE METABOLISM OF NORMAL PLASMA PROTEINS AND GAMMA-MYELOMA PROTEIN IN MICE BEARING PLASMA-CELL TUMORS

9 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19178

Finally! The Brambell receptor (FcRB). Mediator of transmission of immunity and protection from catabolism for IgG.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19178

Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19178

The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19178

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19178

Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19178

Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19178

Metabolism of immunoglobulins

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19178

The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19178

CA 72-4 radioimmunoassay for the detection of the TAG-72 carcinoma-associated antigen in serum of patients.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19178

Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19178

The multichain interleukin-2 receptor: a target for immunotherapy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19178

The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19178

Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19178

Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19178

Proliferation of normal human promyelocytes and myelocytes after a single pulse stimulation by purified GM-CSF or G-CSF.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19178

The neu-oncogene product in serum and tissue of patients with breast carcinoma

24 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.95.4.1752

Shedding of GD2 ganglioside by human neuroblastoma.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.95.4.1752

Biophysical characterization of a recombinant soluble interleukin 2 receptor (Tac). Evidence for a monomeric structure

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.95.4.1752

A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9465089

12 December 2020

inferred from PubMed ID database lookup

A clinical trial of anti-idiotype therapy for B cell malignancy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9465089

12 December 2020

inferred from PubMed ID database lookup

Metabolism of I-131-labelled human albumin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9465089

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1073/PNAS.95.4.1752

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465089%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

0 references

release_ix5maey4fbfxvgcpf4qyxm42va

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ix5maey4fbfxvgcpf4qyxm42va

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9465089%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

PubMed publication ID

9465089

1 reference